We sought to transcriptomically characterize the effect of integrin Ã3 expression on breast cancer cell responses to the microtubule-inhibiting chemotherapeutic agent docetaxel. Experiments were perf

NIAID Data Ecosystem60

Additional file 2: of Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours

乳腺癌耐药性

肿瘤分子分型

Table S1. Table indicating with which public dataset each sample is associated. Table S2. Differentially expressed genes between long-term treated and pre-treatment dormant tumours. Table S3. Enriched

NIAID Data Ecosystem50

Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression. Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression

乳腺癌耐药性

长链非编码RNA

In this study, a total of 12 differentially expressed lncRNAs were established through lncRNA sequencing analysis. Lnc005620 is one of the novel intronic lncRNAs which is highly expressed in Epi-R MDA

NIAID Data Ecosystem90

Effect of Vistusertib alone of in combination with fulvestrant in human breast cancer PDX models of acquired endocrine resistance

乳腺癌耐药性

临床前药物联合治疗

Combined therapy of vistusertib with fulvestrant showed synergy in estrogen receptor positive PDX models of resistance to endocrine therapy and delayed tumour progression after cessation of therapy. T

NIAID Data Ecosystem50

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

资源简介：

相关数据集